-+ 0.00%
-+ 0.00%
-+ 0.00%

Raised 2026 Revenue Guidance With Softer Earnings Could Be A Game Changer For VEON (VEON)

Simply Wall St·08/03/2026 21:20:31
语音播报
  • In July 2026, VEON Ltd. reported second-quarter 2026 results showing sales of US$1,271 million and net income of US$122 million, alongside higher first-half revenues but lower earnings compared with the prior year.
  • On the same day, VEON also raised its full-year 2026 revenue growth guidance to a 15%–18% year-over-year range, signaling greater management confidence despite compressed earnings.
  • Next, we will examine how VEON’s higher 2026 revenue growth guidance might influence its existing investment narrative around digital expansion.

We've uncovered the 9 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

VEON Investment Narrative Recap

To own VEON, you need to believe its push into digital services and fintech can offset thinner telecom margins and volatile emerging-market currencies. The latest guidance hike to 15%–18% revenue growth for 2026 strengthens the near term revenue catalyst, but the sharp drop in net income keeps execution risk front and center, especially around profitability and balance sheet flexibility. Overall, the news supports the growth story but does not remove the main risk around earnings quality and volatility.

The most relevant recent announcement here is VEON’s upgraded 2026 revenue growth guidance, first lifted in March and then raised again alongside Q2 results. Together with rising sales in Q1 and Q2 2026, this frames a clearer near term catalyst around top line expansion, even as first half net income and margins remain well below last year. For investors, that contrast between stronger revenues and weaker profits is key to judging how sustainable VEON’s digital expansion really is.

Yet behind the higher revenue guidance, investors should still be aware of the company’s exposure to currency swings and refinancing needs in its core markets...

Read the full narrative on VEON (it's free!)

VEON's narrative projects $5.7 billion revenue and $645.7 million earnings by 2029. This requires 7.6% yearly revenue growth and an earnings increase of about $113.7 million from $532.0 million.

Uncover how VEON's forecasts yield a $83.44 fair value, a 60% upside to its current price.

Exploring Other Perspectives

VEON 1-Year Stock Price Chart
VEON 1-Year Stock Price Chart

Before this earnings beat on revenue and profit compression, the most optimistic analysts were assuming 2028 earnings near US$843 million and 7.8 percent annual revenue growth, so you should weigh those upbeat digital growth expectations against the risk that heavy investment could delay profitability and consider how both views might shift after this latest update.

Explore 5 other fair value estimates on VEON - why the stock might be worth just $50.69!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

  • A great starting point for your VEON research is our analysis highlighting 3 key rewards and 3 important warning signs that could impact your investment decision.
  • Our free VEON research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate VEON's overall financial health at a glance.

Want Some Alternatives?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.